Hanne Mørck Nielsen

Hanne Mørck Nielsen



1995-2000 PhD, Royal Danish School of Pharmacy, DK and LACDR, Leiden, NL
1989-1995 MSc (pharm), Royal Danish School of Pharmacy, DK


2012-2015 Management Development courses at the University of Copenhagen 1,2,3
2015 Responsible conduct of Research, UCPH, DK
2013-2014 Leading the Virtual Company - PasteurProgram 2013, Harvard Business School, Boston, US and Danish National Advanced Technology Foundation, DK (August 2013-May 2014)2011 CIP Supervised Teaching Session Feedback & Recommendations, University of Cph, DK
2010 Projektledelse for forskere 1+2, University of Cph, DK
2010 Ledelsesudvikling, University of Cph, DK
2008 Research group leader course, University of Cph, DK
2007 Supervision of PhD students, University of Cph, DK


2017 Danish Medicines Agency member (biologiudvalget)
2016 Danish Medicines Agency member (farmaciudvalget)
2015 AcademiaNet member (by nomination)
2014 Advisory Editorial Board member, Journal of Pharmaceutical Sciences
2003 Co-referee on international Ph.D. thesis´s (ETH Zürich, 2003 and 2005)
2003 Examiner on national (2003, 2008, 2009, 2010, 2011, 2012x2) and international Ph.D. thesis´s (2007, 2011)
2001-2002  Post Doctoral Fellowship, Alfred Benzon Foundation, Denmark
2001 Board member of the Biopharmaceutical section of the Danish Pharmaceutical Society


2017-2022 Grant holder, Novo Nordisk Foundation, Project Leader and Principal Investigator at the Center for Biopharmaceuticals and Biobarriers in Drug Delivery
2016-2019 Grant holder/manager, Danish Council for Independent Research: Saliva-reppelent, mucoadhesive nanofiber-based hybrid systems for sublingual delivery of biopharmaceuticals
2015-2017 Grant holder/manager, Danish Council for Independent Research (Quantitative 19F NMR technology for analysis of complex biological matrices from cellular uptake studies: optimization of delivery of biologics using peptide-based delivery systems)
2013-2016 Task manager and steering committee member (Danish National Advanced Technology Foundation (DNATF), project CombioTx)
2012-2017 Managing board member and work package leader, IMI JU EU Project COMPACT –Collaboration on the Optimization of Macromolecular Pharmaceutical Access to Cellular Targets
2012 Section Chair Section for Biologics
2011-2017 Managing board member and task manager Danish National Advanced Technology Foundation (DNATF) project (Unique IPN technology prevents bacterial resistance)
2010-2015 Task manager Danish Agency for Science Technology and Innovation (DanCARD Centre)
2008-2012 Task manager and steering committee member (DNATF project Autologous Cell Therapy)
2006-2010 Task manager, DNATF project (Transcutaneous Vaccination)
2006-2009 TM and board member, Innovative Consortium Danish Agency for Science Technology and Innovation (BioEnCap Consortium)
2004-2012 Head of PHARMA research group Biomacromolecular Drug Delivery


2018 Cell-penetrating peptides – implications for drug delivery (tentative), Frontiers in Delivery of Therapeutics conference, Tartu, Estonia, 21st-24th August
2018 Nanoparticles design for delivery of antimicrobials (tentative), National Meeting of the Swedish Chemical Society, Lund, Sweden, 17th-20th June 2018
2018 Drug delivery systems for antimicrobials, Hamburg, The Hamburg Centre for Ultrafast Imaging (CUI), 19th-21st March 2018
2018 Conjugation to cell-penetrating peptides influences drug delivery propensity and safety, nanoPT2018 International Conference, Lisbon, Portugal, 7th-9th February 2018
2017 Mucoadhesion using small deformation rheology revisited, Nordic Rheology Conference, Copenhagen, DK, 14th-15th September 2017
2017 Tailored formulation design and biobarrier insight: Prerequisites for converting biological molecules into medicine, Shenyang University invited talk, Shenyang, China, 26th April 2017
2017 Improving delivery of biopharmaceuticals through biobarriers by designed drug delivery systems, Symposium on Industrial and Physical Pharmacy 2017, Shenyang, China, 24th-25th April 2017


Number of publications: 116
Citations: 3237 H-index: 34
I10 index: 75


PhD (Pharm) MSc (Pharm)

ID: 1299091